4-difluorophenylaMino)acetic acid
|
- $60 - $1292
- Product name: 4-difluorophenylaMino)acetic acid
- CAS: 901187-90-4
- MF: C8H7F2NO2
- MW: 187.14
- EINECS:
- MDL Number:MFCD06849848
- Synonyms:4-difluorophenylaMino)acetic acid;N-(2,4-difluorophenyl)glycine;Glycine, N-(2,4-difluorophenyl)-
4 prices
Selected condition：
Brand
- ChemBridge Corporation
- Matrix Scientific
- TRC
Package
- 100mg
- 250mg
- 500mg
- 1g
- ManufacturerChemBridge Corporation
- Product numberBB-4045122
- Product descriptionN-(2,4-difluorophenyl)glycine 95%
- Packaging250mg
- Price$64
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number144828
- Product description2-(2,4-Difluorophenylamino)acetic acid 95%
- Packaging500mg
- Price$922
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number144828
- Product description2-(2,4-Difluorophenylamino)acetic acid 95%
- Packaging1g
- Price$1292
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD457438
- Product descriptionN-(2,4-difluorophenyl)glycine
- Packaging100mg
- Price$60
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| ChemBridge Corporation | BB-4045122 | N-(2,4-difluorophenyl)glycine 95% | 250mg | $64 | 2021-12-16 | Buy |
| Matrix Scientific | 144828 | 2-(2,4-Difluorophenylamino)acetic acid 95% | 500mg | $922 | 2021-12-16 | Buy |
| Matrix Scientific | 144828 | 2-(2,4-Difluorophenylamino)acetic acid 95% | 1g | $1292 | 2021-12-16 | Buy |
| TRC | D457438 | N-(2,4-difluorophenyl)glycine | 100mg | $60 | 2021-12-16 | Buy |
Properties
Boiling point :338.1±42.0 °C(Predicted)
Density :1.457±0.06 g/cm3(Predicted)
pka :3.73±0.10(Predicted)
Density :1.457±0.06 g/cm3(Predicted)
pka :3.73±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|